AMG 714 Expanded Access Program
Latest Information Update: 09 May 2019
At a glance
- Drugs Ordesekimab (Primary)
- Indications Coeliac disease
- Focus Expanded access; Therapeutic Use
- Sponsors Amgen
- 23 Feb 2018 New trial record
Latest Information Update: 09 May 2019